Defendant Name: Opko Health Inc.

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 68375N10

Document Reference: comp24262

Document Details

Legal Case Name SEC v. Barry C. Honig, John Stetson, Michael Brauser, John R. O'Rourke III, Mark Groussman, Phillip Frost, Robert Ladd, Elliot Maza, Brian Keller, John H. Ford, Alpha Capital Anstalt, ATG Captial LLC, Frost Gamma Investments Trust, GRQ Consultants, Inc., HS Contrarian Investments, LLC, Grander Holdings, Inc., Melechdavid, Inc., Opko Health, Inc., Southern Biotech, Inc., and Stetson Capital Investments Inc.
Document Name Complaint and Jury Demand
Document Date 07-Sep-2018
Document Format Civil Proceeding
Case Number 18-cv-08175
Federal District Court New York, Southern District of New York
Allegation Type Market Manipulation
Document Summary The Court stated: "This case involves three highly profitable "pump-and-dump" schemes perpetrated by Honig, Stetson, Brauser, O'Rourke, Groussman, and Frost, and their entities GRQ, SCI, Grander, HSCI, Melechdavid, ATG, Opko, FGIT, and Southern Biotech from 2013 through 2018 in the stock of three public companies (Company A, Company B, and Company C) that, while enriching Defendants by millions of dollars, left retail investors holding virtually worthless shares."

Related Documents:

LR-24262 07-Sep-2018 Litigation Release
SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
On September 7, 2018, the SEC issued a litigation release regarding charges against Opko Health Inc., stating: "The Securities and Exchange Commission today charged a group of ten individuals and ten associated entities for their participation in long-running fraudulent schemes that generated over $27 million from unlawful stock sales and caused significant harm to retail investors who were left holding virtually worthless stock."
2018-182 07-Sep-2018 Press Release--Civil Action
SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
On September 7, 2018, the SEC issued a press release regarding charges against Opko Health Inc., stating: "The Securities and Exchange Commission today charged a group of ten individuals and ten associated entities for their participation in long-running fraudulent schemes that generated over $27 million from unlawful stock sales and caused significant harm to retail investors who were left holding virtually worthless stock."
court_doc78_18-cv-08175 10-Jan-2019 Court Docket Document
Final Judgment as to Opko Health, Inc.
The Court stated: "The Securities and Exchange Commission having filed a Complaint and Defendant OPKO Health, Inc. having entered a general appearance; consented to the Court's jurisdiction over Defendant and the subject matter of this action; consented to entry of this Final Judgment without admitting or denying the allegations of the Complaint (except as to jurisdiction); waived findings of fact and conclusions of law; and waived any right to appeal from this Final Judgment."